Insulet Corp (Insulet) is a medical devices company that develops, manufactures and distributes insulin management systems for people suffering from insulin-dependent diabetes. The company’s flagship product, OmniPod insulin management system, is an insulin infusion device meant for continuous subcutaneous insulin infusion (CSII) therapy. It includes: the OmniPod Insulin Management System (OmniPod), the OmniPod DASH Insulin Management System (OmniPod DASH), its digital mobile OmniPod platform.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company's research and development endeavors are primarily concentrated on enhancing the Omnipod System. This includes incorporating new features and functions that will provide users with more convenience and economic benefits. The company's innovation programs have been created with the goal of simplifying user interaction with its systems. This is achieved through algorithm advancements that enhance the outcomes of using the system. The company also seeks to extract insights and value from its growing datasets and analytics. Additionally, users are provided with the freedom to choose their preferred sensor and smartphone integrations. In FY2022, the company spent US$180.2 million on its R&D activities, which grew 12.5% YoY, and as a percentage of revenue, stood at 13.8%. As of December 2022, the company had over 260 patents in the US and certain other countries; and had over 250 patent applications pending.